Information for "Competing interests (from DOI: 10.1038/s41392-020-0110-5)"

Basic information

Display title	Competing interests (from DOI: 10.1038/s41392-020-0110-5)
Default sort key	Competing interests (from DOI: 10.1038/s41392-020-0110-5)
Page length (in bytes)	304
Page ID	13424
Page content language	en - English
Page content model	wikitext
Indexing by robots	Allowed
Number of redirects to this page	0
Counted as a content page	Yes
Wikibase.slis.ua.edu item ID	Q8492
Central description	Publication: "Targeting cancer stem cell pathways for cancer therapy" published as Signal Transduct Target Ther; 2020 ; 5 8; DOI: 10.1038/s41392-020-0110-5

Page protection

Edit	Allow all users (infinite)
Move	Allow all users (infinite)

View the protection log for this page.

Edit history

Page creator	Maintenance script (talk \| contribs)
Date of page creation	11:46, 20 May 2020
Latest editor	Admin (talk \| contribs)
Date of latest edit	12:04, 23 May 2020
Total number of edits	2
Total number of distinct authors	2
Recent number of edits (within past 90 days)	0
Recent number of distinct authors	0

Page properties

Transcluded templates (6)	Templates used on this page: Template:Infobox (view source) Template:Infobox publicationsection (view source) Template:Template other (view source) Module:Entity (view source) Module:Infobox (view source) Module:Navbar (view source)
Wikibase.slis.ua.edu entities used in this page	Bibliography (from DOI: 10.1038/s41392-020-0110-5) Title Targeting cancer stem cell pathways for cancer therapy (DOI: 10.1038/s41392-020-0110-5) Title Section 1: Introduction (from DOI: 10.1038/s41392-020-0110-5) Title Section 2: The concept of CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 2.1: Biological characteristics of CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 2.2: Isolation and identification of CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3: Factors regulating CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.1: Major transcription factors in CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.2: Major signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.2.1: Wnt signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.2.2: Notch signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.2.3: Hh signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.2.4: NF-kappaB signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.2.5: JAK-STAT signaling pathway (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.2.7PI3K/AKT/mTOR signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.2.8: PPAR signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.2.9: Interactions between signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.3: The microenvironment of CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.3.1: Vascular niche microenvironments and CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.3.2: The hypoxia microenvironment and CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.3.3: Tumor-associated macrophages and CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.3.4: Cancer-associated fibroblasts and CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.3.5: Cancer-associated MSCs and CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.3.6: Extracellular matrix and CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 3.3.7: Exosomes in the TME and CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 4: Therapeutic targeting of CSCs (from DOI: 10.1038/s41392-020-0110-5) Title Section 4.1: Agents targeting CSC-associated surface biomarkers in clinical trials (from DOI: 10.1038/s41392-020-0110-5) Title Section 4.2: Agents targeting CSC-associated signaling pathways in clinical trials (from DOI: 10.1038/s41392-020-0110-5) Title Section 4.3: Targeting the CSC microenvironment (from DOI: 10.1038/s41392-020-0110-5) Title Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5) Title Section 5: Conclusions and perspectives (from DOI: 10.1038/s41392-020-0110-5) Title Competing interests (from DOI: 10.1038/s41392-020-0110-5) Title Statement: P146 Statement: P94 Sitelink Statement: P78 Statement: P125

Information for "Competing interests (from DOI: 10.1038/s41392-020-0110-5)"

Basic information

Page protection

Edit history

Page properties

Navigation menu

Personal tools

Namespaces

Variants

Views

More

Search

Navigation

Tools